Pharmacological inhibition of carbonic anhydrases 9 and 12 attenuates monocrotaline-induced pulmonary hypertension in rats
A. Petrovic (Giessen, Germany), D. Kosanovic (Giessen, Germany), O. Pak (Giessen, Germany), J. Schneider (Giessen, Germany), A. Sydykov (Giessen, Germany), N. Weissmann (Giessen, Germany), W. Seeger (Giessen, Germany), R. Schermuly (Giessen, Germany)
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Petrovic (Giessen, Germany), D. Kosanovic (Giessen, Germany), O. Pak (Giessen, Germany), J. Schneider (Giessen, Germany), A. Sydykov (Giessen, Germany), N. Weissmann (Giessen, Germany), W. Seeger (Giessen, Germany), R. Schermuly (Giessen, Germany). Pharmacological inhibition of carbonic anhydrases 9 and 12 attenuates monocrotaline-induced pulmonary hypertension in rats. 1417
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: